Individuals with known allergies to glutathione or its components should avoid supplementation
Key Takeaways: BPC-157 is a lab-made peptide based on a natural stomach protein that may help the body repair muscles, tendons, ligaments, and the gut, based on early research
Survodutide: GI adverse events occurred in 75% of survodutide patients vs 42% placebo
The medication is expected to launch in 2026
They have expanded rapidly from a weight-loss-focused platform into a broader wellness company, though peptide therapy and GLP-1 medications remain their primary revenue drivers
Higher marker concentrations reduce the bulk material needed to achieve target active levels, directly impacting capsule sizing, tablet compression characteristics, and excipient load in dietary supplement formulations